Panacea Life Sciences Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Panacea Life Sciences Holdings, Inc. (PLSH) reported Revenue from Contract with Customer, Excluding Assessed Tax of $1.06 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2024-05-06
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2024-03-31 was $1.06M, a 55.94% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-12-31 was $960.50K, a 195.73% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-09-30 was $347.85K, a 5.02% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2023-06-30 was $399.13K, a 14.98% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $2.38M, a 46.59% increase from fiscal 2022.
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.63M, a 21.01% decline from fiscal 2021.
- Panacea Life Sciences Holdings, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $2.06M.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.06M 10-Q · filed 2024-05-06 | $2.02M derived: sum of 2 quarters · filed 2024-05-06 | $2.36M derived: sum of 3 quarters · filed 2024-05-06 | $2.76M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | $960.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.31M derived: sum of 2 quarters · filed 2024-04-01 | $1.71M derived: sum of 3 quarters · filed 2024-04-01 | $2.38M 10-K · filed 2024-04-01 |
| 2023-09-30 | $347.85K 10-Q · filed 2023-11-14 | $746.98K derived: sum of 2 quarters · filed 2023-11-14 | $1.42M 10-Q · filed 2023-11-14 | $1.75M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-06-30 | $399.13K 10-Q · filed 2023-08-15 | $1.08M 10-Q · filed 2023-08-15 | $1.40M derived: sum of 3 quarters · filed 2024-05-06 | $1.77M derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-03-31 | $677.48K 10-Q · filed 2024-05-06 | $1.00M derived: sum of 2 quarters · filed 2024-05-06 | $1.37M derived: sum of 3 quarters · filed 2024-05-06 | $1.84M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $324.79K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $691.03K derived: sum of 2 quarters · filed 2024-04-01 | $1.16M derived: sum of 3 quarters · filed 2024-04-01 | $1.63M 10-K · filed 2024-04-01 |
| 2022-09-30 | $366.24K 10-Q · filed 2023-11-14 | $835.72K derived: sum of 2 quarters · filed 2023-11-14 | $1.30M 10-Q · filed 2023-11-14 | $1.95M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $469.47K 10-Q · filed 2023-08-15 | $935.95K 10-Q · filed 2023-08-15 | $1.58M derived: sum of 3 quarters · filed 2023-08-15 | $2.17M derived: sum of 4 quarters · filed 2023-08-15 |
| 2022-03-31 | $466.47K 10-Q · filed 2023-05-12 | $1.11M derived: sum of 2 quarters · filed 2023-05-12 | $1.70M derived: sum of 3 quarters · filed 2023-05-12 | $2.01M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $645.95K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.23M derived: sum of 2 quarters · filed 2023-03-30 | $1.55M derived: sum of 3 quarters · filed 2023-03-30 | $2.06M 10-K · filed 2023-03-30 |
| 2021-09-30 | $588.04K 10-Q · filed 2022-11-14 | $901.54K derived: sum of 2 quarters · filed 2022-11-14 | $1.41M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $313.50K 10-Q · filed 2022-08-15 | $825.63K 10-Q · filed 2022-08-15 |